Doç. Dr. MİNE ARAZ

Yayın Ağı

Makaleler 101

1. Safety of repeated trans-arterial radioembolization with multi-compartment dosimetry

SOYDAL Ç., Demir B., ARAZ M., Mesci I., ÇELEBİOĞLU E. C., KÜÇÜK N. Ö.

Annals of Nuclear Medicine , cilt.39, sa.12, ss.1306-1318, 2025 (SCI-Expanded, Scopus)

2. Exploring the metabolic-immune score in advanced NSCLC treated with immunotherapy

KARAOĞLAN B. B., DURSUN E., Mesci İ., ARAZ M., KÖKSOY E. B.

Scientific Reports , cilt.15, sa.1, 2025 (SCI-Expanded)

3. Initial Multicenter Experience with [(161)Tb]Tb-PSMA in [(177)Lu]Lu-PSMA-Refractory Metastatic Castration-Resistant Prostate Cancer: Preliminary Results.

Kucuk N. Ö., Coskun N., Araz M., Alan Selcuk N., Berberoglu K., Ozdemir E. C., et al.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine , 2025 (SCI-Expanded, Scopus)

4. Prediction of [177Lu]Lu-PSMA-617 treatment response with [68Ga]Ga-PSMA-11 PET-derived variables and correlation of the overall survival with serum PSA and PSMA PET-based response criteria.

Ozkan E., Demir B., Soydal Ç., Araz M., Dursun E., Kucuk N. Ö., et al.

Revista espanola de medicina nuclear e imagen molecular , ss.500208, 2025 (Hakemli Dergi)

5. Integrated Dedicated Liver ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging of Hepatocellular Carcinoma and Correlations of Positron Emission Tomography with Diffusion-Weighted Imaging and Morphological Findings

Soydal Ç., Demir B., Kuru Oz D., Dursun E., Araz M., Kucuk N. Ö.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. ⁶⁸Ga DOTATATE PET/MR Imaging of Well-Differentiated Primary and Metastatic Liver Neuroendocrine Tumors: Unified Evaluation and Correlations of PET, DCE, DWI, and T2-weighted Images

Soydal Ç., Demir B., Akkus Gunduz P., Baltacioglu M. H., Araz M., Kuru Oz D., et al.

CLINICAL NUCLEAR MEDICINE , cilt.50, sa.9, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Hashimoto's encephalopathy in psychiatric inpatients: neuropsychiatric morbidity, diagnostic challenges and treatment

İlhan R. S., Can K. C., Yalçın Şahiner Ş., Duman B., Çolak B., Kır Y., et al.

FRONTIERS IN PSYCHIATRY , cilt.16, 2025 (SCI-Expanded, SSCI, Scopus)

8. Suvmax of the lesion should be considered in the treatment plan for stage I non-small cell lung cancer

KOCAMAN G., Ibrahımov F., KAHYA Y., ARAZ M., ELHAN A. H., ENÖN S.

Annals of Nuclear Medicine , cilt.39, sa.8, ss.792-798, 2025 (SCI-Expanded, Scopus)

9. Retrospective chart review of cases of steroid-responsive catatonia: exploring a potential autoimmune aetiology

İlhan R. S., Rogers J. P., Can K. C., Duman B., Çolak B., Saka M. C., et al.

BJPSYCH OPEN , cilt.11, sa.5, 2025 (SCI-Expanded, SSCI, Scopus)

10. Granulomatous Inflammation of Liver Mimicking Malignancy on ⁶⁸Ga-FAPI PET/CT

ARAZ M., Dursun E., Mesci I., KONCA C., SOYDAL Ç., ÖZKAN E., et al.

CLINICAL NUCLEAR MEDICINE , cilt.50, sa.7, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

11. Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival

SOYDAL Ç., ARAZ M., Demir B., ÖNEŞ T., SÖNMEZOĞLU K., Selcuk N. A., et al.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine , cilt.66, sa.7, ss.1097-1104, 2025 (SCI-Expanded)

12. Diagnostic performance of fluorine-18-fluorodeoxyglucose PET/MRI for detection of disease recurrence in differentiated thyroid cancer: a compartment-based analysis

Özkan E., Ünal S., Akkuş P., Peker E., Araz M., Dursun E., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.46, sa.3, ss.230-238, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. The prognostic role of pan-immune inflammation value in patients with metastatic castration resistance prostate cancer treated with Lutetium-177 (177Lu)-PSMA-617

YAZGAN S. C., Yekeduz E., ARAZ M., BÖLEK H., KÜÇÜK N. Ö., ÜRÜN Y.

Prostate , cilt.85, sa.1, ss.90-96, 2025 (SCI-Expanded, Scopus)

14. Comparative evaluation of the performance of 18F-PSMA-1007 PET/CT and 68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence Evaluación comparativa de los resultados de la PET/TC con [18F]F-PSMA-1007 y la PET/TC con [68Ga]Ga-PSMA-11 en los pacientes con recidiva bioquímica de cáncer de próstata

Inal G., SOYDAL Ç., Demir B., ARAZ M., ÜRÜN Y., BALTACI S., et al.

Revista Espanola de Medicina Nuclear e Imagen Molecular , 2025 (SCI-Expanded, Scopus)

15. PET/MR in Breast Cancers

ARAZ M.

NUCLEAR MEDICINE SEMINARS , cilt.10, 2024 (Hakemli Dergi)

16. Advancements in the Management of Synchronous Colorectal Liver Metastases: A Comprehensive Review of Surgical, Systemic, and Local Treatment Modalities.

Karaoğlan B. B., Öz D., Araz M., Akyol C., Utkan G.

Current oncology reports , cilt.26, sa.7, ss.791-803, 2024 (SCI-Expanded, Scopus)

17. Prognostic Importance of 18F-FDG Positron Emission Tomography in Uterine Cervical Cancer

Soydal Ç., Baltacıoğlu M. H., Araz M., Demir B., Dursun E., Taşkın S., et al.

Molecular Imaging and Radionuclide Therapy , cilt.33, sa.3, 2024 (ESCI)

18. Posterior cingulate cortex hyperactivity in conversion disorder: a PET/MRI study

TATLI S. Z., ARAZ M., ÖZKAN E., PEKER E., Erden M., ŞENTÜRK CANKORUR V.

Frontiers in Psychiatry , cilt.15, 2024 (SCI-Expanded, SSCI, Scopus)

19. Comparison of (68)Ga-PSMA PET/CT and (18)F-PSMA PET/CT of a Patient with Prostate Cancer Recurrence on Urinary Bladder Wall.

Soydal Ç., Demir B., Sütçü G., Araz M., Küçük N. Ö.

Molecular imaging and radionuclide therapy , cilt.32, sa.2, ss.150-152, 2023 (ESCI, TRDizin)

20. Long-term effects of radioiodine treatment on thyroid functions and ultrasonographic features in patients with toxic adenoma and toxic multinodular goitre

Koç I., Bahçecioğlu A. B., AVCI MERDİN F., ARAZ M., ERDOĞAN M. F.

Annals of Nuclear Medicine , cilt.37, sa.6, ss.371-379, 2023 (SCI-Expanded, Scopus)

21. The relationship between 18F-FCH uptake intensity and cell content in parathyroid lesions

ARAZ M., SOYDAL Ç., SÜTÇÜ G., Kivrak H., Sak S., KIR K. M., et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , cilt.280, sa.6, ss.2905-2910, 2023 (SCI-Expanded, Scopus)

22. The Role of (18)F-FDOPA PET/CT in Recurrent Medullary Thyroid Cancer Patients with Elevated Serum Calcitonin Levels.

Araz M., Soydal Ç., Demir Ö., Gökcan M. K., Küçük N. Ö.

Molecular imaging and radionuclide therapy , cilt.32, sa.1, ss.1-7, 2023 (ESCI, TRDizin)

23. Clinical value of fluorine-18-fluorodeoxyglucose PET/MRI for liver metastasis in colorectal cancer: a prospective study

Akkus Gunduz P., ÖZKAN E., KURU ÖZ D., SOYDAL Ç., ARAZ M., ERDEN G. A., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.44, sa.2, ss.150-160, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. Can Serum Thyroglobulin Levels Help to Identify the Involved Neck Compartment of Differentiated Thyroid Carcinoma?

Bahcecioglu A. B., Ozkan E., Araz M., Elhan A. H., Erdogan M. F.

HORMONE AND METABOLIC RESEARCH , cilt.54, sa.10, ss.658-663, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. Significance of metabolic tumor volume and total lesion uptake measured using Ga-68 labelled prostate-specific membrane antigen PET/CT in primary staging of prostate cancer

KUBİLAY E., Akpinar Ç., OĞUZ E. S., ARAZ M., SOYDAL Ç., BALTACI S., et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , cilt.40, sa.9, 2022 (SCI-Expanded, Scopus)

26. A Rare Pitfall in Bone Mineral Densitometry Gaucher Disease

ARAZ M., SÜTÇÜ G., Surucu Kara L., Eminoglu T., ÖZKAN E.

CLINICAL NUCLEAR MEDICINE , cilt.47, sa.8, 2022 (SCI-Expanded)

27. Liver Blood Pool Imaging and Selective Spleen Scintigraphy

ARAZ M.

NUCLEAR MEDICINE SEMINARS , cilt.8, 2022 (Hakemli Dergi)

28. Elevated Angiogenic Factor Levels After Transarterial Radioembolization for Colorectal Cancer Liver Metastases May Predict a Poor Prognosis

Soydal Ç., Araz M., Durmaz M., Özkan E., Ergüder B. İ., Küçük N. Ö., et al.

Molecular Imaging and Radionuclide Therapy , cilt.31, sa.2, ss.114-122, 2022 (Scopus, TRDizin) Sürdürülebilir Kalkınma

29. Detectability of 18F-choline PET/MR in primary hyperparathyroidism

Araz M., Nak D., Soydal Ç., Peker E., Erden İ., Küçük N. Ö.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , cilt.279, sa.5, ss.2583-2589, 2022 (SCI-Expanded, Scopus)

30. Aumento difuso de la captación en los conductos biliares intrahepáticos en18F-FDG-PET/TC en un caso de colangitis esclerosante primaria

Araz M., Gündüz P., Baltacıoğlu M. H., Soydal Ç., Kır K. M.

REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR , cilt.41, ss.4-5, 2022 (SCI-Expanded, Scopus)

31. Prognostic value of metabolic parameters on baseline 18F-FDG PET/CT in small cell lung cancer

Araz M., Soydal Ç., Özkan E., Sen E., Nak D., Kucuk O. N., et al.

QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.66, sa.1, ss.61-66, 2022 (SCI-Expanded, Scopus)

32. Correlation of cancer status and brown adipose tissue activity on 18F-flourodeoxyglucose positron emission tomography/computed tomography

ARAZ M., GÜLPINAR B., GÜNDÜZ P., ÖZKAN E., ŞAHİN M.

Turkish Journal of Clinics and Laboratory , cilt.13, ss.52-58, 2022 (Hakemli Dergi) Sürdürülebilir Kalkınma

33. Negative Histopathological Prognostic Factors Affecting Morbidity in T1 Differentiated Thyroid Carcinoma

Araz M., Özkan E., Gündüz P., Soydal Ç., Küçük N. Ö., Kır K. M.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , cilt.37, ss.56-62, 2022 (SCI-Expanded, Scopus)

34. Myocardial perfusion SPECT findings in postCOVID period

Araz M., Soydal Ç., Sütçü G., Demir B., Özkan E.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.49, sa.3, ss.889-894, 2022 (SCI-Expanded, Scopus)

35. Can Radiomics Analyses in F-18-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?

Araz M., Soydal Ç., Gündüz P., Kırmızı B. A., Bakırarar B., Sak S., et al.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.31, sa.1, ss.49-56, 2022 (ESCI, Scopus, TRDizin)

36. Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma

SOYDAL Ç., VARLI B., ARAZ M., BAKIRARAR B., TAŞKIN S., ORTAÇ U. F.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.3, ss.762-769, 2022 (SCI-Expanded, Scopus, TRDizin)

37. Prognostic importance of prostatic specific antigen response in patients who received Lutetium-177 prostate-specific membrane antigen treatment for castration resistant prostate cancer

Soydal Ç., Araz M., Ürün Y., Nak D., Özkan E., Küçük N. Ö.

QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.65, sa.3, ss.282-286, 2021 (SCI-Expanded, Scopus)

38. Role of Thyroglobulin Doubling Time in Differentiated Thyroid Cancer and Its Relationship with Demographic-Histopathologic Risk Factors and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters

Araz M., Soydal Ç., Özkan E., Akkus P., Nak D., Küçük N. Ö., et al.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , cilt.36, sa.5, ss.425-432, 2021 (SCI-Expanded, Scopus)

39. Gallbladder Uptake Mimicking Liver Metastasis on Lu-177-DOTATATE Posttherapy Scan Gallbladder Uptake on Lu-177-DOTATATE Scan

Araz M., Baltacıoğlu M. H., Saglam S., Ozguven M. A., Küçük N. Ö.

CLINICAL NUCLEAR MEDICINE , cilt.46, sa.3, 2021 (SCI-Expanded, Scopus)

40. A Rare Extramedullary Presentation of Multiple Myeloma: Paraspinal Muscle Involvement Revealed by FDG PET/CT

Özkan E., Araz M., Cengiz Seval G., Nak D., Beksaç M.

TURKISH JOURNAL OF HEMATOLOGY , cilt.38, sa.1, ss.69-71, 2021 (SCI-Expanded, Scopus, TRDizin)

41. Should the Place of Radioactive Iodine Whole Body Scintigraphy in Follow-up of Differentiated Thyroid Cancer Reevaluated in the Era of SPECT/CT?

Araz M., Küçük N. Ö.

Nuclear Medicine Seminars , cilt.7, 2021 (Hakemli Dergi)

42. The Role of Nuclear Medicine in the Diagnosis of NETs

Özkan E., Araz M.

Nuclear Medicine Seminars , cilt.7, 2021 (Hakemli Dergi)

43. Ga-68 DOTATATE PET/CT in the Evaluation of Therapy Response in Neuroendocrine Tumors

Küçük N. Ö., Araz M.

Nuclear Medicine Seminars , cilt.7, 2021 (Hakemli Dergi)

44. Use of Recombinant TSH in the Treatment and Monitoring of Well-Differentiated Thyroid Cancers

Özkan E., Araz M.

Nuclear Medicine Seminars , cilt.7, 2021 (Hakemli Dergi)

45. Intense F-18-Flourodeoxyglucose Uptake in Brachial Plexus of Patients with Brachial Plexopathy

Soydal Ç., Gündüz P., Araz M., Utkan G.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.29, sa.2, ss.79-81, 2020 (ESCI, Scopus, TRDizin)

46. Intense 18F-Flourodeoxyglucose Uptake in Brachial Plexus of Patients with Brachial Plexopathy

SOYDAL Ç., AKKUŞ P., ARAZ M., UTKAN G.

Molecular Imaging and Radionuclide Therapy , cilt.29, sa.2, ss.79-81, 2020 (ESCI, Scopus, TRDizin)

47. Incidental F-18-Fluorocholine Uptake in an Esophageal Diverticulum F-18-FCH in an Esophageal Diverticulum

Araz M., Cinel M., Soydal Ç., Özkan E., Küçük N. Ö.

CLINICAL NUCLEAR MEDICINE , cilt.45, sa.4, 2020 (SCI-Expanded, Scopus)

48. Radionuclide Methods for Pain Palliation

Araz M., Akkuş P.

Nuclear Medicine Seminars , cilt.6, sa.1, ss.20-27, 2020 (Hakemli Dergi)

49. Developments in Pain Imaging

Soydal Ç., Araz M.

Nuclear Medicine Seminars , cilt.6, sa.1, ss.1-4, 2020 (Hakemli Dergi)

50. Four Atypical Parathyroid Adenomas Detected by Dual Phase Tc-99m MIBI SPECT

Araz M., Cayir D., Koybasioglu F. F., Karabacak H., Cakal E.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.29, sa.1, ss.33-36, 2020 (ESCI, Scopus, TRDizin)

51. An uncommon presentation of diffuse large B cell lymphoma with multiple peripheral nerve involvement demonstrated BY 18F-FDG PET/CT

Araz M., Soydal Ç., Ozturk C., Özkan E., Demirer T.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.47, sa.1, ss.218-219, 2020 (SCI-Expanded, Scopus)

52. Analysis of prognostic factors in patients receiving transarterial radioembolization for unresectable hepatocellular carcinoma

Soydal Ç., Araz M., Nak D., Akku P., Baltacıoğlu M. H., Bilgic S., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.41, sa.1, ss.73-77, 2020 (SCI-Expanded, Scopus)

53. First Experience of C-11-Methionine PET in Multiple Myeloma in Turkey

Ozkan E., Cengiz Seval G., Araz M., Kucuk N. Ö., Beksaç M.

TURKISH JOURNAL OF HEMATOLOGY , cilt.39, sa.1, ss.66-67, 2020 (SCI-Expanded)

54. Can we differentiate histologic subtypes of neuroendocrine tumour liver metastases at a single phase contrast-enhanced CT-correlation with Ga-68 DOTATATE PET/CT findings

Gülpınar B., Peker E., Soydal Ç., Araz M., Elhan A. H.

BRITISH JOURNAL OF RADIOLOGY , cilt.93, sa.1106, 2020 (SCI-Expanded, Scopus)

55. Comparison of bone scintigraphy and Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography in the detection of bone metastases of prostate carcinoma

Soydal Ç., Nak D., Araz M., Akkus P., Ürün Y., Özkan E., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.40, sa.12, ss.1243-1249, 2019 (SCI-Expanded, Scopus)

56. F-18-Flourodeoxy glucose PET-computed tomography in testicular carcinoma: diagnostic and prognostic value

Soydal Ç., Araz M., Ürün Y., Gülpınar B., Nak D., Özkan E., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.40, sa.12, ss.1268-1274, 2019 (SCI-Expanded, Scopus)

57. Ga-68-DOTATATE Uptake in Pancreatic Metastasis of Renal Cell Carcinoma Mimicking Pancreatic Neuroendocrine Tumor

Soydal Ç., Nak D., Araz M., Demirkazık A., Küçük N. Ö.

CLINICAL NUCLEAR MEDICINE , cilt.44, sa.10, ss.795-796, 2019 (SCI-Expanded, Scopus)

58. Intense Pituitary 18F-Fluorodeoxyglucose Positron Emission Tomography Uptake in a Patient with Diabetes Insipidus

Soydal Ç., Nak D., Araz M., Taçyıldız N., Küçük N. Ö.

BALKAN MEDICAL JOURNAL , cilt.36, sa.4, ss.253-254, 2019 (SCI-Expanded)

59. Nuclear Medicine Applications in Diagnosis of Urological Tumors

Araz M., Ürün Y.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.18, sa.2, ss.80-88, 2019 (ESCI)

60. The efficacy of fluorine-18-choline PET/CT in comparison with Tc-99m-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism

Araz M., Soydal Ç., Özkan E., Kır K. M., İbiş E., Güllü S., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.39, sa.11, ss.989-994, 2018 (SCI-Expanded, Scopus)

61. Clinical Significance of Incidental Pituitary TC-99m MIBI Uptake on Parathyroid Spect and Factors Affecting Uptake Intensity

Araz M., Cayir D., Ucan B., Dilli A., Cakal E.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , cilt.33, sa.7, ss.295-299, 2018 (SCI-Expanded, Scopus)

62. The relationship between semiquantitative parameters derived from technetium-99m metoxyisobutylisonitrile dual-phase parathyroid single-photon emission computed tomography images and disease severity in primary hyperparathyroidism

Cayir D., ARAZ M., Yalcindag A., Cakal E.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.39, sa.4, ss.304-311, 2018 (SCI-Expanded, Scopus)

63. Inguinal Endometriosis Visualized on I-131 Whole Body Scan

Cayir D., ARAZ M., Apaydin M., Cakal E.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.27, sa.1, ss.52-54, 2018 (ESCI, Scopus, TRDizin)

64. Karaciğer tümörlerinde intraarteriyel mikroküre tedavisi sonuçları

ARAZ M., KÜÇÜK N. Ö.

Türkiye Klinikleri , ss.26-31, 2018 (Hakemli Dergi)

65. Incidental Tc-99m Methylene Diphosphonate Uptake in an Active Thyroid Nodule

Cayir D., ARAZ M., Akin S., Karakose M., Cakal E.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.26, sa.3, ss.128-130, 2017 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

66. Cyclosporine and Vancomycin

Cayir D., ARAZ M., Filik M., Erdogan M.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.26, sa.3, ss.124-127, 2017 (ESCI)

67. Bifid Pelvis Appearance and Yo-Yo Reflux on Dynamic Renal Scintigraphy: Two Case Reports

ARAZ M., ÇAYIR D.

International Journal of Nuclear Medicine Research , cilt.4, sa.1, ss.15-18, 2017 (Hakemli Dergi)

68. Evaluation of Residual Thyroid Tissue with Tc-99m MIBI in Differential Thyroid Carcinoma Patients: A Case Report

ÇAYIR D., ARAZ M., UÇAN B., ÇAKAL E.

International Journal of Nuclear Medicine Research , cilt.4, sa.1, ss.13-14, 2017 (Hakemli Dergi)

69. Radioiodine Therapy of Benign Thyroid Diseases

ÇAYIR D., ARAZ M.

International Journal of Nuclear Medicine Research , cilt.4, sa.1, ss.6-12, 2017 (Hakemli Dergi)

70. Factors affecting the sensitivity of Tc-99m methoxyisobutylisonitrile dual-phase parathyroid single photon emission computed tomography in primary hyperparathyroidism

ARAZ M., Cayir D., Erdogan M., Ucan B., Cakal E.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.38, sa.2, ss.117-123, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

71. F-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography for Other Thyroid Cancers: Medullary, Anaplastic, Lymphoma and So Forth

ARAZ M., Cayir D.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.26, sa.1, ss.1-8, 2017 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

72. Comparison of 18F-FDG PET/CT and ceCT results in the assessment of RCC recurrence

ÖZKAN E., ARAZ M., SOYDAL Ç., ARAS G.

Studies on Stem Cells Research and Thearpy , cilt.3, sa.1, ss.1-5, 2017 (Hakemli Dergi)

73. May preablative thyroglobulin level be a prognostic indicator for papillary thyroid cancer?

ÖZKAN E., SOYDAL Ç., ARAZ M., GENÇ Y., KÜÇÜK N. Ö.

Clinical and Medical Investigations , cilt.2, sa.1, ss.1-16, 2017 (Hakemli Dergi)

74. Scintigraphic Appearance of an Incidental Giant Hydronephrosis in a Pediatric Patient

Cayir D., ARAZ M.

Journal of Nephrology and Urology Research , cilt.4, sa.1, ss.1-2, 2016 (Hakemli Dergi)

75. Giant Urinary Bladder Visualised on Tc-99m MDP Whole Body Bone Scan

Cayir D., ARAZ M., GÜLTEKİN S. S.

Journal of Nephrology and Urology Research , cilt.4, sa.1, ss.3-4, 2016 (Hakemli Dergi)

76. Unexpected Appearance of Ectopic Mediastinal Toxic Nodulary Thyroid Hyperplasia in a Case of Recurrent Hyperthyroidism

ARAZ M., ÇAYIR D., ÇOLAK BOZKURT N., YAZICI Ü., ÇAKAL E.

International Journal of Nuclear Medicine Research , cilt.3, sa.2, 2016 (Hakemli Dergi)

77. Scintigraphic evaluation of renal functional damage in volatile substance abusers

Cayir D., Demirel K., Korkmaz M., ARAZ M., Koca G.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.37, sa.6, ss.623-631, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

78. Association between mean platelet volume and bone mineral density in postmenopausal women

AYPAK C., Türedi Ö., Bircan M. A., Civelek G. M., ARAZ M.

Journal Of Physical Therapy Science , cilt.28, sa.6, ss.1753-1758, 2016 (Scopus) Sürdürülebilir Kalkınma

79. Impact of 18F-FDG PET/CT for Detecting Primary Tumor Focus in Patients with Histopathologically Proven Metastasis

ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö.

International Journal of Nuclear Medicine Research , cilt.3, 2016 (Hakemli Dergi)

80. Association of haematological parameters with bone mineral density in elderly diabetic women

Aypak C., Turedi O., Bircan M. A., ARAZ M.

ACTA CLINICA BELGICA , cilt.70, sa.5, ss.339-344, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

81. The role of 18F-NaF PET/CT in metastatic bone disease

ARAZ M., Aras G., KÜÇÜK N. Ö.

JOURNAL OF BONE ONCOLOGY , cilt.4, sa.3, ss.92-97, 2015 (SCI-Expanded, Scopus)

82. Assessment of recurrence rates in papillary thyroid microcarcinoma patients with and without histopathological risk factors after radioiodine ablation treatment

SOYDAL Ç., ARAZ M., ÖZKAN E., Arslantas E., KÜÇÜK N. Ö., Aras G.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.36, sa.2, ss.109-113, 2015 (SCI-Expanded, Scopus)

83. Different Uptake Patterns of Tc-99m MDP on Three Phase Bone Scan in a Neurofibromatosis Type I Patient with Multiple Neurofibromas and Neurofibrosarcoma: Case Report

ÖRS Ç. D., ARAZ M., BAKIRHAN Ü., ERDOĞAN M., DİLLİ A.

Türkiye Klinikleri Tip Bilimleri Dergisi , cilt.35, sa.4, ss.279-283, 2015 (Scopus)

84. Bilobar Thyroid Pyramidal Lobe: Original Image

ÖRS Ç. D., ARAZ M.

Türkiye Klinikleri Tip Bilimleri Dergisi , cilt.35, sa.4, ss.287-288, 2015 (Scopus)

85. Use of Osteoporosis Medications Among Turkish Patients

Aypak C., Turedi O., Bircan M. A., ARAZ M., Yikilkan H., Akbiyik D. I., et al.

JOURNAL OF CLINICAL PHARMACOLOGY , cilt.54, sa.11, ss.1318-1319, 2014 (SCI-Expanded)

86. Prognostic Importance of F-18-FDG Uptake Pattern of Hepatocellular Cancer Patients Who Received SIRT

KÜÇÜK N. Ö., SOYDAL Ç., ARAZ M., Bilgic S., İBİŞ E.

CLINICAL NUCLEAR MEDICINE , cilt.38, sa.7, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

87. Evaluation of the Response to Selective Internal Radiation Therapy in Patients With Hepatocellular Cancer According to Pretreatment Tc-99m-MAA Uptake

KÜÇÜK N. Ö., SOYDAL Ç., ARAZ M., ÖZKAN E., Aras G.

CLINICAL NUCLEAR MEDICINE , cilt.38, sa.4, ss.252-255, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

88. Intense Ga-68 Dotatate Uptake in Recurrent MTC Patient

SOYDAL Ç., ÖZKAN E., ARAZ M., KÜÇÜK N. Ö., DEMİRER T.

World Journal of Endocrine Surgery , cilt.4, sa.3, ss.118-119, 2012 (Scopus)

89. Unexpected F-18-FDG uptake in an ocular prosthesis

ÖZKAN E., ARAZ M., SOYDAL Ç., Aras G.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.39, sa.9, ss.1517-1518, 2012 (SCI-Expanded)

90. Serum carcinoembryonic antigen measurement, abdominal contrast-enhanced computed tomography, and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of colorectal cancer recurrence: a correlative study

ÖZKAN E., SOYDAL Ç., ARAZ M., Aras G.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.33, sa.9, ss.990-994, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

91. The Additive Clinical Value of F-18-FDG PET/CT in Defining the Recurrence of Disease in Patients With Differentiated Thyroid Cancer Who Have Isolated Increased Antithyroglobulin Antibody Levels

ÖZKAN E., SOYDAL Ç., ARAZ M., Aras G., İBİŞ E.

CLINICAL NUCLEAR MEDICINE , cilt.37, sa.8, ss.755-758, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

92. Detection of Intraluminal Tracheal Metastasis of Thyroid Papillary Carcinoma by F-18-FDG PET/CT

ÖZKAN E., ARAZ M., SOYDAL Ç., KÜÇÜK N. Ö., İBİŞ E.

CLINICAL NUCLEAR MEDICINE , cilt.37, sa.6, 2012 (SCI-Expanded, Scopus)

93. The role of F-18-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels

ÖZKAN E., SOYDAL Ç., ARAZ M., KIR K. M., İBİŞ E.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.33, sa.4, ss.395-402, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

94. Clinical Experience of F-18-FDG PET/CT in Soft Tissue and Osseous Sarcomas

ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.22, sa.3, ss.163-169, 2012 (SCI-Expanded, Scopus, TRDizin)

95. The role of intraoperative gamma probe and parathyroid hormone measurement in the localization of intrathyroidal parathyroid adenoma

SOYDAL Ç., GENÇ V., ARAZ M., AKYOL C., KÜÇÜK N. Ö.

World Journal of Endocrine Surgery , cilt.4, sa.2, ss.77-78, 2012 (Scopus)

96. Differentiated thyroid carcinomas in childhood: clinicopathologic results of 26 patients

ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , cilt.24, sa.9-10, ss.739-742, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

97. The role of 18F-FDG-PET/CT in the preoperative staging and posttherapy follow up of gastriccancer: Comparison with spiral CT

ÖZKAN E., ARAZ M., SOYDAL Ç., KÜÇÜK N. Ö.

WORLD JOURNAL OF SURGICAL ONCOLOGY , cilt.9, 2011 (SCI-Expanded, Scopus)

98. Nuclear medicine applications in pediatric oncology: Review Pediatrik onkolojide nükleer tip uygulamalari

ARAZ M., KÜÇÜK N. Ö.

Turkiye Klinikleri Pediatri , cilt.20, sa.2, ss.151-168, 2011 (Scopus) Sürdürülebilir Kalkınma

99. Ocular involvement in mantle cell lymphoma detected by F 18 FDG PET CT

Özkan E., Laçin S., Soydal Ç., Araz M., Küçük N. Ö.

Molecular Imaging and Radionuclide Therapy , cilt.20, sa.1, ss.36-37, 2011 (TRDizin)

100. Pediatrik onkolojide nükleer tıp uygulamaları

ARAZ M., KÜÇÜK N. Ö.

Türkiye Klinikleri Journal of Pediatr , cilt.20, sa.2, ss.151-168, 2011 (Hakemli Dergi)

101. Differentiated thyroid corcinomas in childhood: clinicopathologic results of 26 patients

ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö.

Journal of Pediatric Endocrinology and Metabolism , cilt.24, sa.9-10, ss.739-742, 2011 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 123

1. Correlation Between PRIMARY Scores in Ga-68 PSMA PET and Histological ISUP Grades in Prostate Cancer

SOYDAL Ç., ÇİDEMAL M., ARAZ M., KÜÇÜK N. Ö.

Annuals Congress of the European Association of Nuclear Medicine, 4 - 08 Ekim 2025, (Tam Metin Bildiri)

2. Interim Analysis of Effect of Hypoxia on F-18 MISO PET to Response to Lu-177 PSMA Treatment (LuMISO)Trial

SOYDAL Ç., DURSUN E., DEMİR B., SÜTÇÜ G., ARAZ M., KÜÇÜK N. Ö.

Annuals Congress of the European Association of Nuclear Medicine, 4 - 08 Ekim 2025, (Tam Metin Bildiri)

3. Variations in F-18-FMISO Physiological Uptake

ARAZ M., MESCİ İ., DURSUN E., SOYDAL Ç., KÜÇÜK N. Ö.

Annuals Congress of the European Association of Nuclear Medicine, 4 - 08 Ekim 2025, (Tam Metin Bildiri)

4. Quantitative Tc-99m MIBI SPECT/CT parameters can predict malignancy in indeterminate thyroid nodulespreliminary results

ARAZ M., MESCİ İ., DURSUN E., SOYDAL Ç., AKSU O., ERASLAN E., et al.

Annuals Congress of the European Association of Nuclear Medicine, 4 - 08 Ekim 2025, (Tam Metin Bildiri)

5. F-18 FES PET’in Metastatik Meme Kanserinde Östrojen Reseptör Heterojenitesinin Gösterilmesindeki Yeri

DURSUN E., ÖZKAN E., SOYDAL Ç., KÜÇÜK N. Ö., ARAZ M., DEMİR B., et al.

37.Ulusal Nükleer Tıp Kongresi, 9 - 13 Nisan 2025, (Tam Metin Bildiri)

6. Çok Kompartmanlı Dozimetri ile Tekrarlayan Transarteriyel Radyoembolizasyonun Güvenilirliği

SOYDAL Ç., DEMİR B., ARAZ M., ÇELEBİOĞLU E. C., KÜÇÜK N. Ö.

37.Ulusal Nükleer Tıp Kongresi, 9 - 13 Nisan 2025, (Tam Metin Bildiri)

7. Pankreasta ve Uterusta Fizyolojik Ga-68 FAPİ Tutulumu

MESİCİ İ., SOYDAL Ç., DURSUN E., ARAZ M., KÜÇÜK N. Ö.

37.Ulusal Nükleer Tıp Kongresi, 9 - 13 Nisan 2025, (Tam Metin Bildiri)

8. Osteoporoz ve periodontitis tedavisinin sistemik-mandibular kemik mineral yoğunluğu, yaşam kalitesine (QUALEFFO-41) etkisi / Osteoporosis and periodontitis treatment impact on bone density and quality of life

KARAASLAN R., FENTOĞLU Ö., GÖKÇAY CANPOLAT A., BAĞIŞ N., ARAZ M., BAŞ AKSU Ö.

Türk Periodontoloji Derneği 53. Bilimsel Kongresini ve 31. Bilimsel Sempozyumu, Türkiye, 07 Kasım 2024, (Tam Metin Bildiri)

9. Osteoporoz ve Periodontitis Tedavisinin Sistemik-Mandibular Kemik Mineral Yoğunluğu Ve Yaşam Kalitesine (QUALEFFO-41) Etkisi.

KARAASLAN R., BAŞ AKSU Ö., ARAZ M., GÖKÇAY CANPOLAT A., BAĞIŞ N., ORHAN H., et al.

Türk Periodontoloji Derneği 53. Uluslararası Bilimsel Kongresi, Türkiye, 14 Kasım 2024, (Tam Metin Bildiri)

10. Lutesyum-177 (177Lu)-PSMA-617 ile tedavi edilen metastatik kastrasyon dirençli prostat kanseri hastalarında Pan-İmmün inflamasyon değerinin prognostik Rolü

YAZGAN S. C., YEKEDÜZ E., ARAZ M., BÖLEK H., KÜÇÜK N. Ö., ÜRÜN Y.

On TARGED Master Oncology, 26 - 29 Ekim 2024, (Tam Metin Bildiri)

11. Comparison of Ga-68 FAPI PET/CT and F18-FDG PET/CT in primary staging of breast cancer

ARAZ M., SOYDAL Ç., DURSUN E., MESCİ İ., KONCA C., ÖZKAN E., et al.

Annuals Congress of the European Association of Nuclear Medicine, 19 - 23 Ekim 2024, cilt.51, ss.17, (Tam Metin Bildiri)

12. Dual FES/FDG PET/CT imaging to predict therapy response in patients with estrogen receptor-positive recurrent or metastatic breast cancer: Preliminary Results

DURSUN E., ÖZKAN E., YAŞAR H. A., ARAZ M., AKSOY S., ÜRÜN Y., et al.

Annuals Congress of the European Association of Nuclear Medicine, 19 - 23 Ekim 2024, cilt.51, ss.493-494, (Tam Metin Bildiri)

13. F18-FCH uptake in thyroid parenchymal diseases

ARAZ M., SOYDAL Ç., DEMİR B., SÜTÇÜ G., GÖKÇAY CANPOLAT A., KÜÇÜK N. Ö.

Annuals Congress of the European Association of Nuclear Medicine, 19 - 23 Ekim 2024, cilt.51, ss.367-368, (Tam Metin Bildiri)

14. Transarterial radioembolization (TARE) in Colorectal metastasis of liver (TACOME) trial

SOYDAL Ç., ARAZ M., DEMİR B., ÖNEŞ T., SÖNMEZOĞLU K., ALAN SELÇUK N., et al.

Annuals Congress of the European Association of Nuclear Medicine, 19 - 23 Ekim 2024, cilt.51, ss.407-408, (Tam Metin Bildiri)

15. Comparison of Ga-68 FAPI PET/CT and F18-FDG PET/CT in primary staging of breast cancer

ARAZ M., SOYDAL Ç., DURSUN E., Mesci İ., KONCA C., ÖZKAN E., et al.

Annual Congress of the European Association of Nuclear Medicine October 19–23, 2024 Hamburg, Germany, Hamburg, Almanya, 19 Ekim 2024, cilt.51, ss.17, (Özet Bildiri)

16. Diverse etiologies and targeted therapeutic approaches in catatonia: a retrospective cohort study

İlhan R. S., Çolak B., Can K. C., Erdoğan S., Yılmaz R., Araz M., et al.

37th ECNP Congres, Milan, İtalya, 21 - 24 Eylül 2024, (Tam Metin Bildiri)

17. Case report: levetiracetam-induced catatonia

Emri C., Özçelik K., İLHAN R. S., ERDOĞAN S., DUMAN B., ÇOLAK B., et al.

37th ECNP Congress, Milan, İtalya, 21 Eylül 2024, (Özet Bildiri)

18. Lu-177 PSMA tedavisine yanıtın RECIP kriterleri ve PSA düzeyi ile değerlendirilmesi ve sağkalım ile korelasyonu

ÖZKAN E., DEMİR B., SOYDAL Ç., DURSUN E., ARAZ M., ÜRÜN Y., et al.

36.Ulusal Nükleer Tıp Kongresi, 8 - 12 Mayıs 2024, (Tam Metin Bildiri)

19. Biyokimyasal nüks izlenen prostat Ca hastalarında F-18 PSMA PET/BT'nin başarısının değerlendirilmesi.

SÜTÇÜ G., SOYDAL Ç., ARAZ M., ÜRÜN Y., SÜER E., BALTACI S., et al.

36.Ulusal Nükleer Tıp Kongresi, 8 - 12 Mayıs 2024, (Tam Metin Bildiri)

20. Hybrıd F18-FDG PET/MRI in endometrial cancer: staging accuracy, quantitative analysis, and imaging characteristics of histological subtypes

KURU ÖZ D., ARAZ M., Yılmazer Zorlu N. S., VARLI B., SOYDAL Ç., TAŞKIN S., et al.

European Congress of Radiology, ECR 2024, Avusturya, 28 Şubat - 03 Mart 2024, (Tam Metin Bildiri)

21. Steroid-Responsive catatonia associated with possible autoimmune enchephalitis - A Case Series

İlhan R. S., Duman B., Can K. C., Çolak B., Yılmaz R., Erdoğan S., et al.

36th ECNP Congress, Barcelona, İspanya, 7 - 10 Ekim 2023, (Tam Metin Bildiri)

22. Intravenous immunoglobulin responsive postinfectious Covid-19 Catatonia - A case report

Keser E., Kılıç U., İlhan R. S., Can K. C., Saydan B., Duman B., et al.

36Th ECNP Congress, Barcelona, İspanya, 7 - 10 Ekim 2023, (Tam Metin Bildiri)